Clinical Trials in Fairfax, United States
Locations / Fairfax, United States
Delta Trials records 98 clinical trials conducted in Fairfax, United States, making it a notable site of clinical research activity. These trials across 370 distinct therapeutic areas, reflecting the scope and diversity of clinical research in this location. Since 2020, 2 trials in this location were terminated, reflecting shifts in research priorities or feasibility. Delta Trials updates this record as new data becomes available from ClinicalTrials.gov, providing a versioned view of how research activity in Fairfax has changed over time.
98
Total Trials
370
Conditions
2
Terminated since 2020
Browse by condition (370 total)
- Carcinoma, non-small-cell lung 10 trialsAll Carcinoma, non-small-cell lung trials
- Non-small cell lung cancer 5 trialsAll Non-small cell lung cancer trials
- Multiple myeloma 4 trialsAll Multiple myeloma trials
- Advanced solid tumor 3 trialsAll Advanced solid tumor trials
- Metastatic malignant solid neoplasm 3 trialsAll Metastatic malignant solid neoplasm trials
- Malignant solid neoplasm 3 trialsAll Malignant solid neoplasm trials
- Acute myeloid leukemia 3 trialsAll Acute myeloid leukemia trials
- Recurrent ovarian carcinoma 3 trialsAll Recurrent ovarian carcinoma trials
- Recurrent malignant solid neoplasm 3 trialsAll Recurrent malignant solid neoplasm trials
- All Stage iiia lung non-small cell cancer ajcc v7 trials
- All Stage ii lung non-small cell cancer ajcc v7 trials
- All Stage ib lung non-small cell carcinoma ajcc v7 trials
- All Locally advanced malignant solid neoplasm trials
- Exocrine pancreas carcinoma 2 trialsAll Exocrine pancreas carcinoma trials
- All Stage iii lip and oral cavity cancer ajcc v8 trials
- Esophageal carcinoma 2 trialsAll Esophageal carcinoma trials
- Recurrent melanoma 2 trialsAll Recurrent melanoma trials
- All Ebv-positive diffuse large b-cell lymphoma, not otherwise specified trials
- All Acute myeloid leukemia, myelodysplasia-related trials
- Endometrial cancer 2 trialsAll Endometrial cancer trials